Network Pharmacology Combined with GEO Database Identifying the Mechanisms and Molecular Targets of Polygoni Cuspidati Rhizoma on Peri-implants

Overview

Journal Sci Rep

Specialty Science

Date 2022 May 17

PMID 35581339

Authors

Chao Shan

Xiaowei Ji

Zeyu Wu

Jin Zhao

Affiliations

Soon will be listed here.

Abstract

Peri-implants is a chronic disease leads to the bone resorption and loss of implants. Polygoni Cuspidati Rhizoma (PCRER), a traditional Chinese herbal has been used to treat diseases of bone metabolism. However, its mechanism of anti-bone absorption still remains unknown. We aimed to identify its molecular target and the mechanism involved in PCRER potential treatment theory to Peri-implants by network pharmacology. The active ingredients of PCRER and potential disease-related targets were retrieved from TCMSP, Swiss Target Prediction, SEA databases and then combined with the Peri-implants disease differential genes obtained in the GEO microarray database. The crossed genes were used to protein-protein interaction (PPI) construction and Gene Ontology (GO) and KEGG enrichment analysis. Using STRING database and Cytoscape plug-in to build protein interaction network and screen the hub genes and verified through molecular docking by AutoDock vina software. A total of 13 active compounds and 90 cross targets of PCRER were selected for analysis. The GO and KEGG enrichment analysis indicated that the anti-Peri-implants targets of PCRER mainly play a role in the response in IL-17 signaling, Calcium signaling pathway, Toll-like receptor signaling pathway, TNF signaling pathway among others. And CytoHubba screened ten hub genes (MMP9, IL6, MPO, IL1B, SELL, IFNG, CXCL8, CXCL2, PTPRC, PECAM1). Finally, the molecular docking results indicated the good binding ability with active compounds and hub genes. PCRER's core components are expected to be effective drugs to treat Peri-implants by anti-inflammation, promotes bone metabolism. Our study provides new thoughts into the development of natural medicine for the prevention and treatment of Peri-implants.

Citing Articles

Exploration of compatibility rules and discovery of active ingredients in TCM formulas by network pharmacology.

Liu Y, Li X, Chen C, Ding N, Ma S, Yang M Chin Herb Med. 2024; 16(4):572-588.

PMID: 39606260 PMC: 11589340. DOI: 10.1016/j.chmed.2023.09.008.

Network pharmacology and bioinformatic integrative analysis reveals candidate gene targets and potential therapeutic of East Kalimantan propolis against hepatocellular carcinoma.

Kustiawan P, Siregar K, Jauhar M, Ramadhan D, Mardliyati E, Syaifie P Heliyon. 2024; 10(21):e39142.

PMID: 39524833 PMC: 11544044. DOI: 10.1016/j.heliyon.2024.e39142.

Uncovering the anti-breast cancer activity potential of east Kalimantan propolis by In vitro and bioinformatics analysis.

Kustiawan P, Siregar K, Syaifie P, Zein Muttaqin F, Ibadillah D, Jauhar M Heliyon. 2024; 10(13):e33636.

PMID: 39071605 PMC: 11283153. DOI: 10.1016/j.heliyon.2024.e33636.

Network pharmacology to unveil the mechanism of suanzaoren decoction in the treatment of alzheimer's with diabetes.

Chen T, Lei Y, Li M, Liu X, Zhang L, Cai F Hereditas. 2024; 161(1):2.

PMID: 38167125 PMC: 10762922. DOI: 10.1186/s41065-023-00301-z.

Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening.

Gong X, Chen T, Lin C, Ping H, Tong X, Zhang K Biomed Res Int. 2023; 2023:2501596.

PMID: 37124933 PMC: 10137196. DOI: 10.1155/2023/2501596.

References

Wong S, Chin K, Ima-Nirwana S . Quercetin as an Agent for Protecting the Bone: A Review of the Current Evidence. Int J Mol Sci. 2020; 21(17). PMC: 7503351. DOI: 10.3390/ijms21176448. View

Ding N, Lu Y, Cui H, Ma Q, Qiu D, Wei X . Physalin D inhibits RANKL-induced osteoclastogenesis and bone loss via regulating calcium signaling. BMB Rep. 2020; 53(3):154-159. PMC: 7118355. View

Xie W, Meng X, Zhai Y, Zhou P, Ye T, Wang Z . Panax Notoginseng Saponins: A Review of Its Mechanisms of Antidepressant or Anxiolytic Effects and Network Analysis on Phytochemistry and Pharmacology. Molecules. 2018; 23(4). PMC: 6017639. DOI: 10.3390/molecules23040940. View

Li H, Chen Z, Zhong X, Li J, Li W . Mangiferin alleviates experimental peri-implantitis via suppressing interleukin-6 production and Toll-like receptor 2 signaling pathway. J Orthop Surg Res. 2019; 14(1):325. PMC: 6798411. DOI: 10.1186/s13018-019-1387-3. View

Boyce B, Li P, Yao Z, Zhang Q, Badell I, Schwarz E . TNF-alpha and pathologic bone resorption. Keio J Med. 2005; 54(3):127-31. DOI: 10.2302/kjm.54.127. View

Kormas I, Pedercini C, Pedercini A, Raptopoulos M, Alassy H, Wolff L . Peri-Implant Diseases: Diagnosis, Clinical, Histological, Microbiological Characteristics and Treatment Strategies. A Narrative Review. Antibiotics (Basel). 2020; 9(11). PMC: 7700146. DOI: 10.3390/antibiotics9110835. View

Park E, Kum S, Wang C, Park S, Kim B, Schuller-Levis G . Anti-inflammatory activity of herbal medicines: inhibition of nitric oxide production and tumor necrosis factor-alpha secretion in an activated macrophage-like cell line. Am J Chin Med. 2005; 33(3):415-24. DOI: 10.1142/S0192415X05003028. View

Hua Y, Bi R, Li Z, Li Y . Resveratrol treatment promotes titanium implant osseointegration in diabetes mellitus rats. J Orthop Res. 2020; 38(10):2113-2119. DOI: 10.1002/jor.24651. View

Schierano G, Pejrone G, Brusco P, Trombetta A, Martinasso G, Preti G . TNF-alpha TGF-beta2 and IL-1beta levels in gingival and peri-implant crevicular fluid before and after de novo plaque accumulation. J Clin Periodontol. 2008; 35(6):532-8. DOI: 10.1111/j.1600-051X.2008.01224.x. View

10.

Cheng G, Jiang Q, Deng A, Wang Y, Liu J, Zhou Q . CD31 induces inflammatory response by promoting hepatic inflammatory response and cell apoptosis. Eur Rev Med Pharmacol Sci. 2018; 22(21):7543-7550. DOI: 10.26355/eurrev_201811_16296. View

11.

Keiser M, Roth B, Armbruster B, Ernsberger P, Irwin J, Shoichet B . Relating protein pharmacology by ligand chemistry. Nat Biotechnol. 2007; 25(2):197-206. DOI: 10.1038/nbt1284. View

12.

Kanehisa M, Sato Y, Kawashima M . KEGG mapping tools for uncovering hidden features in biological data. Protein Sci. 2021; 31(1):47-53. PMC: 8740838. DOI: 10.1002/pro.4172. View

13.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View

14.

Liu Z, Luo Z, Meng Q, Zhong P, Hu Y, Shen X . Network pharmacology-based investigation on the mechanisms of action of Morinda officinalis How. in the treatment of osteoporosis. Comput Biol Med. 2020; 127:104074. DOI: 10.1016/j.compbiomed.2020.104074. View

15.

Kwon T, Wang C, Salem D, Levin L . Nonsurgical and surgical management of biologic complications around dental implants: peri-implant mucositis and peri-implantitis. Quintessence Int. 2020; 51(10):810-820. DOI: 10.3290/j.qi.a44813. View

16.

Darabi E, Kadkhoda Z, Amirzargar A . Comparison of the levels of tumor necrosis factor-α and interleukin-17 in gingival crevicular fluid of patients with peri-implantitis and a control group with healthy implants. Iran J Allergy Asthma Immunol. 2013; 12(1):75-80. DOI: 012.01/ijaai.7580. View

17.

Ha J, Choi H, Lee Y, Kwon H, Song Y, Kim H . CXC chemokine ligand 2 induced by receptor activator of NF-kappa B ligand enhances osteoclastogenesis. J Immunol. 2010; 184(9):4717-24. DOI: 10.4049/jimmunol.0902444. View

18.

Wei Y, Lan Y, Liu Y, Meng L, Xu Q, Xie H . Platelet-endothelial cell adhesion molecule-1 gene polymorphism and its soluble level are associated with ischemic stroke. DNA Cell Biol. 2009; 28(3):151-8. DOI: 10.1089/dna.2008.0817. View

19.

Barootchi S, Ravida A, Tavelli L, Wang H . Nonsurgical treatment for peri-implant mucositis: A systematic review and meta-analysis. Int J Oral Implantol (Berl). 2020; 13(2):123-139. View

20.

Malaguarnera L . Influence of Resveratrol on the Immune Response. Nutrients. 2019; 11(5). PMC: 6566902. DOI: 10.3390/nu11050946. View